Stock Price
2.33
Daily Change
-0.04 -1.69%
Monthly
-20.48%
Yearly
76.52%
Q2 Forecast
2.28

Galectin Therapeutics reported $-2.71M in Interest Income for its fiscal quarter ending in December of 2023.





Interest Income Change Date
AbbVie USD 72M 10M Sep/2025
Galectin Therapeutics USD -2.71M 2.77M Dec/2023
Gilead Sciences USD 95M 7M Dec/2025
Immunic USD -0.24 0.03 Sep/2024
Incyte USD 30.75M 3.97M Dec/2025
Merck USD 96M 27M Sep/2025